Heartsciences Inc (HSCS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
(Values in U.S. thousands)
| 04-2025 | 04-2024 | 04-2023 | 04-2022 | 04-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,765 | -6,605 | -6,354 | -4,828 | -2,452 |
| Depreciation Amortization | 414 | 199 | 197 | 183 | 34 |
| Accounts receivable | -4 | N/A | 2 | -2 | N/A |
| Accounts payable and accrued liabilities | -130 | -183 | 38 | 359 | -21 |
| Other Working Capital | 519 | -504 | 65 | 1,125 | 190 |
| Other Operating Activity | 553 | 1,024 | 278 | -481 | -203 |
| Operating Cash Flow | $-7,413 | $-6,070 | $-5,774 | $-3,644 | $-2,452 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | -65 | -18 | -2 | -1 |
| Purchase Sale Intangibles | -27 | -61 | N/A | N/A | N/A |
| Other Investing Activity | -27 | -61 | 0 | 0 | 0 |
| Investing Cash Flow | $-30 | $-125 | $-18 | $-2 | $-1 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 4,226 | 1,780 |
| Debt Issued | 1,850 | 334 | N/A | 500 | 700 |
| Debt Repayment | -264 | -292 | -398 | 0 | N/A |
| Common Stock Issued | 1,148 | 10,300 | 6,782 | 0 | N/A |
| Other Financing Activity | 0 | 0 | 150 | -885 | 200 |
| Financing Cash Flow | $2,734 | $10,343 | $6,534 | $3,841 | $2,680 |
| Beginning Cash Position | 5,808 | 1,661 | 918 | 724 | 497 |
| End Cash Position | 1,098 | 5,808 | 1,661 | 918 | 724 |
| Net Cash Flow | $-4,710 | $4,147 | $742 | $195 | $227 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,413 | -6,070 | -5,774 | -3,644 | -2,452 |
| Capital Expenditure | -3 | -65 | -18 | -2 | -1 |
| Free Cash Flow | -7,416 | -6,135 | -5,792 | -3,646 | -2,453 |